Associated Papers
Population-Specific Differences in Pathogenic Variants of Genes Associated with Monogenic Parkinson's Disease.
Flores-Ocampo V et al.
Genes, 2025
40282414 (PubMed )
Supplement: genes-16-00454-s001.zip › Supplementary_Tables.xlsx › ST2
Rethinking 'rare' PINK1 Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology.
Yin EP et al.
Journal of Parkinson's Disease, 2025
Clinico-Genetic Profiles of Seven Patients With PINK1-Related Parkinson's Disease: A Case Series From a Tertiary Care Centre in India and a Review of the Literature.
Gunasekaran A et al.
Journal of Movement Disorders, 2024
39294919 (PubMed )
Supplement: jmd-24157-Supplementary-Table-1.pdf
A compound heterozygous PINK1-associated juvenile Parkinson's disease with pregnancy in Chinese.
Li JY et al.
Journal of Neurology, 2021
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays.
Tang Z et al.
Molecules (basel, Switzerland), 2021
Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population.
Diez-Fairen M et al.
Neurobiology of Aging, 2018
Genotype-Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review.
Kasten M et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2018
LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
Azkona G et al.
Molecular Neurobiology, 2018
Parkinson's disease-related gene variants influence pre-mRNA splicing processes.
Gaweda-Walerych K et al.
Neurobiology of Aging, 2016
Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.
McNeill A et al.
Plos One, 2013
Genetic mutations and functions of PINK1.
Kawajiri S et al.
Trends in Pharmacological Sciences, 2011
PINK1-linked parkinsonism is associated with Lewy body pathology.
Samaranch L et al.
Brain : a Journal of Neurology, 2010
Select a paper to view details